|
[Related PubMed/MEDLINE]
Total Number of Papers: 411
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: Ang |
| Long Form |
: angiopoietin |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma. |
AASLD, AFP, BCLC, CEP, cfDNA, CR, DCP, eNOS, HAP, HCC, HGF, HMgb1, IFN-gamma, miRNAs, MLR, NCCN, NLR, NO, NOS, OS, PD, PFS, PLR, PNI, PR, PRISMA, PROSASH, RCTs, RECIST, SAP, SD, SNPs, TACE, TTP, VEGF |
| 2 |
2021 |
A Three-Dimensional Co-Culture Model for Rheumatoid Arthritis Pannus Tissue. |
MTX, RA, VEGF |
| 3 |
2021 |
Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer. |
--- |
| 4 |
2021 |
Association between inflammatory biomarkers and acute respiratory distress syndrome or acute lung injury risk : A systematic review and meta-analysis. |
ALI, ARDS, IL, PAI, TNF |
| 5 |
2021 |
Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma. |
FGF, HCC, VEGF |
| 6 |
2021 |
DL-3-n-butylphthalide suppressed autophagy and promoted angiogenesis in rats with vascular dementia by activating the Shh/Ptch1 signaling pathway. |
Beclin-1, FGF, IF, LC3, NBP, SD, VD, VEGF |
| 7 |
2021 |
Hydroxysafflor Yellow a Promotes Angiogenesis in Rat Brain Microvascular Endothelial Cells Injured by Oxygen-glucose Deprivation/reoxygenation(OGD/R) through SIRT1-HIF-1α-VEGFA Signaling Pathway. |
BMECs, HIF-1alpha, HSYA, OGD/R, PDGF, SIRT1, VEGF |
| 8 |
2021 |
Kinetics of Plasma Cytokines, Angiopoietin-2, and C-Reactive Protein in Dogs With Gastric Dilatation Volvulus. |
CRP, GDV, IFN-gamma, IL, MCP |
| 9 |
2021 |
KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation. |
CNS, eNOS, GB, POP, VEGF |
| 10 |
2021 |
Mucopolysaccharide polysulfate promotes microvascular stabilization and barrier integrity of dermal microvascular endothelial cells via activation of the angiopoietin-1/Tie2 pathway. |
HDMEC, HPC, MPS, PDGF-BB, TEER, TIE2, VE |
| 11 |
2021 |
Patho-Mechanisms for Hemorrhage/Sepsis-Induced Indirect Acute Respiratory Distress Syndrome: A Role for Lung TIE1 and Its Regulation by Neutrophils. |
CLP, EC, HEM, iARDS |
| 12 |
2021 |
Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia. |
ALL, CAR, CRS, R/R, sVCAM, vWF |
| 13 |
2021 |
Recovery of Liver Sinusoidal Endothelial Cells Following Monocrotaline-induced Liver Injury. |
BM, LSECs, LYVE-1, MCT, SOS |
| 14 |
2021 |
Requirement of respiratory support in acute bronchiolitis in infants is linked to endothelial and neutrophil activation. |
CI, NLR, sVCAM-1 |
| 15 |
2021 |
Serum Levels of Markers of Endothelial Activation Are Not Associated with a Positive Blood Culture in Surinamese Children with Suspected Severe Infection. |
--- |
| 16 |
2021 |
The Diagnostic Value of Serum Ang, VEGF, and CRP Combined with the Chinese Medicine Antitumor Formula in the Treatment of Advanced Renal Carcinoma. |
CRP, ROC, VEGF |
| 17 |
2021 |
[Advances of Angiopoietin-Tie axis in vascular and lymphatic system-related diseases]. |
--- |
| 18 |
2020 |
Angiopoietin-2 as a Prognostic Factor in Patients with Incurable Stage IV Colorectal Cancer. |
CRC |
| 19 |
2020 |
Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway. |
EphA, GBM, HIF, PAS, VE, VEGFR, VM |
| 20 |
2020 |
Dexmedetomidine protects against endothelial injury in septic rats induced by cecal ligation and puncture by decreasing angiopoietin 2 and increasing vascular endothelial cadherin levels. |
CLP, DEX, VE |
| 21 |
2020 |
Dynamic changes of angiopoietins and endothelial nitric oxide supply during fluid resuscitation for major gyn-oncological surgery: a prospective observation. |
eNOS |
| 22 |
2020 |
Dysregulation of angiopoietin-Tie-2 axis in ugandan children hospitalized with pneumonia. |
RISC |
| 23 |
2020 |
Effects of cholecalciferol supplementation on serum angiogenic biomarkers in breast cancer patients treated with tamoxifen: A controlled randomized clinical trial. |
BC, HIF, VEGF |
| 24 |
2020 |
Expression of Angiopoietins and Angiogenic Signaling Pathway Molecules in Chronic Subdural Hematomas. |
CSDH, CSF, eIF4E, ELISA, mTOR, PI3K |
| 25 |
2020 |
Inhibition of microRNA-451 is associated with increased expression of Macrophage Migration Inhibitory Factor and mitgation of the cardio-pulmonary phenotype in a murine model of Bronchopulmonary Dysplasia. |
BPD, MIF, miR-451, MLECs, VEGFA |
| 26 |
2020 |
Insight into the Role of Angiopoietins in Ageing-Associated Diseases. |
AADs, VEGF |
| 27 |
2020 |
MicroRNA-126 enhances the biological function of endothelial progenitor cells under oxidative stress via PI3K/Akt/GSK3beta and ERK1/2 signaling pathways. |
AMI, EPC, GSK-3beta, PI3K |
| 28 |
2020 |
miR-205-5p inhibits psoriasis-associated proliferation and angiogenesis: Wnt/beta-catenin and mitogen-activated protein kinase signaling pathway are involved. |
BAMBI, IMQ, MAPK, VEGFA |
| 29 |
2020 |
Nailfold Videocapillaroscopy Findings in Bradykinin-Mediated Angioedema. |
ACE, NVC, VEGF |
| 30 |
2020 |
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma. |
OS, PFS, rGBM, RR, VEGF |
| 31 |
2020 |
Preclinical validation of a novel metastasis-inhibiting Tie1 function-blocking antibody. |
--- |
| 32 |
2020 |
Sulfated glycans engage the Ang-Tie pathway to regulate vascular development. |
HSGAGs |
| 33 |
2020 |
The endogenous capacity to produce proinflammatory mediators by the ex vivo human perfused lung. |
AFC, IL, sTNFR |
| 34 |
2019 |
A collagen IV-derived peptide disrupts alpha5beta1 integrin and potentiates Ang2/Tie2 signaling. |
--- |
| 35 |
2019 |
alpha-Tocopheryl succinate stabilizes the structure of tumor vessels by inhibiting angiopoietin-2 expression. |
CM-TS, TS |
| 36 |
2019 |
Alternative trafficking of Weibel-Palade body proteins in CRISPR/Cas9-engineered von Willebrand factor-deficient blood outgrowth endothelial cells. |
BOECs, cbBOECs, CRISPR, IL, VWD, vWF, WPBs |
| 37 |
2019 |
Angiopoietin: A Novel Neuroprotective/Neurotrophic Agent. |
VEGF |
| 38 |
2019 |
Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential. |
DR |
| 39 |
2019 |
Characterization of a Porcine Model for Von Willebrand Disease Type 1 and 3 Regarding Expression of Angiogenic Mediators in the Nonpregnant Female Reproductive Tract. |
VEGF, VWD, vWF, WT |
| 40 |
2019 |
Endothelial Progenitor and Mesenchymal Stromal Cells in Newborns With Congenital Diaphragmatic Hernia Undergoing Extracorporeal Membrane Oxygenation. |
CDH, ECMO, MSC, VEGF |
| 41 |
2019 |
Impact of HIV-1 infection on the IGF-1 axis and angiogenic factors in pregnant Cameroonian women receiving antiretroviral therapy. |
cART, IGF, MMP |
| 42 |
2019 |
Prognostic value of endothelial biomarkers in refractory cardiogenic shock with ECLS: a prospective monocentric study. |
AUROC, ECMO, VEGF |
| 43 |
2019 |
Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients. |
--- |
| 44 |
2019 |
Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib - Results of NCI/CTEP Protocol 9048. |
RCC, VEGF |
| 45 |
2019 |
The contribution of dietary and plasma folate and cobalamin to levels of angiopoietin-1, angiopoietin-2 and Tie-2 receptors depend on vascular endothelial growth factor status of primary breast cancer patients. |
Tie-2, VEGF-C |
| 46 |
2018 |
A gene-activating skin substitute comprising PLLA/POSS nanofibers and plasmid DNA encoding ANG and bFGF promotes in vivo revascularization and epidermalization. |
bFGF, HUVECs, pDNAs, PLLA, POSS, TMC |
| 47 |
2018 |
Angiogenesis-related gene expression profile in clinical cases of canine cancer. |
VEGF |
| 48 |
2018 |
Angiopoietin-2 promotes extracellular matrix degradation in human degenerative nucleus pulposus cells. |
IDD, IVDs, NF-kappaB |
| 49 |
2018 |
CXCR-4 expression by circulating endothelial progenitor cells and SDF-1 serum levels are elevated in septic patients. |
CXCR, EPC, RAGE, SAPS, SDF, VEGF |
| 50 |
2018 |
Endothelial Activation: The Ang/Tie Axis in Sepsis. |
--- |
| 51 |
2018 |
Expression and secretion of neuregulin-1 in cardiac microvascular endothelial cells treated with angiogenic factors. |
HCMECs, NRG-1, VEGF |
| 52 |
2018 |
Expression of angiogenic factors and plexiform lesions in the lungs of broiler and layer chickens: A comparison. |
EPC, HGF, IL, PAH, TGF, VEGFR |
| 53 |
2018 |
Inhibitory Effects On Retinal Neovascularization by Ranibizumab and sTie2-Fc in An Oxygen-Induced Retinopathy Mouse Model. |
ECs, FITC, HE, IB4, ILM, OIR, PBS, RNV, ROP, RT-PCR, VEGF |
| 54 |
2018 |
Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer. |
COX, FGF, HGF, LEC, LECP, NRP, PDGF, PG, VEGF |
| 55 |
2018 |
Targeting the Tie2-alphavbeta3 integrin axis with bi-specific reagents for the inhibition of angiogenesis. |
Ang2-BD |
| 56 |
2018 |
Tuberculous lymphadenitis is associated with altered levels of circulating angiogenic factors. |
LTBI, PTB, TBL, VEGF |
| 57 |
2018 |
VCAM-1 expression is upregulated by CD34+/CD133+-stem cells derived from septic patients. |
ICU, SAPS, VCAM-1, VEGF |
| 58 |
2018 |
Wu-Tou Decoction Inhibits Angiogenesis in Experimental Arthritis by Targeting VEGFR2 Signaling Pathway. |
CIA, HUVECs, IL, RA, VEGF, WTD |
| 59 |
2018 |
[Current advance in cerebral malaria]. |
CM, CXCL10, CXCL4, pRBCs |
| 60 |
2017 |
Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell Transplantation. |
AML, GVHD, HSCT, VEGF |
| 61 |
2017 |
Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis. |
LTBI, PTB |
| 62 |
2017 |
Bone marrow mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke in type 2 diabetic rats. |
BBB, BMSCs-CM, CM, Tie |
| 63 |
2017 |
Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice. |
Ad, VEGFs |
| 64 |
2017 |
Dimerization of Tie2 mediated by its membrane-proximal FNIII domains. |
ECR, FNIII, sTie2 |
| 65 |
2017 |
Endothelial dysfunction during long-term follow-up in children with STEC hemolytic-uremic syndrome. |
AKI, CIMT, HUS, PWV, STEC |
| 66 |
2017 |
Expression and regulation of Angiopoietins and their receptor Tie-2 in sika deer antler. |
ATRA |
| 67 |
2017 |
Gastric Cancer and Angiogenesis: Is VEGF a Useful Biomarker to Assess Progression and Remission? |
ANGTPL2, GC, IL, MeSH, VEGF |
| 68 |
2017 |
Homocysteine inhibits angiogenesis through cytoskeleton remodeling. |
CAM, EC, Hcy, HUVEC, VEGF |
| 69 |
2017 |
Important signals regulating coronary artery angiogenesis. |
bFGF, HGF, HIF-1, PDGF, TGF-beta, VEGF |
| 70 |
2017 |
Involvement of synovial matrix degradation and angiogenesis in oxidative stress-exposed degenerative rotator cuff tears with osteoarthritis. |
PRP, RCTs, TGF-beta1 |
| 71 |
2017 |
Markers of endothelial damage in patients with chronic kidney disease on hemodialysis. |
CVD, DM, HD, MVs |
| 72 |
2017 |
miR-218 suppresses gastric cancer cell proliferation and invasion via regulation of angiopoietin-2. |
--- |
| 73 |
2017 |
The diagnostic and prognostic value of angiopoietins compared with C-reactive protein and procalcitonin in children with febrile neutropenia. |
CDI, CRP, FUO, MDI, PCT |
| 74 |
2017 |
The Profile of Angiogenic Factors in Vitreous Humor of the Patients with Proliferative Diabetic Retinopathy. |
ELISA, HGF, IL-6, MMP-9, PDR, uPAR, VEGF |
| 75 |
2017 |
Therapeutic targeting of the angiopoietin-TIE pathway. |
VEGF |
| 76 |
2017 |
Tie2 as a novel key factor of microangiopathy in systemic sclerosis. |
IHC, MB, SSc, sTie2, Tg, tsk1, VEGF |
| 77 |
2017 |
TNF-alpha blockade suppresses pericystic inflammation following anthelmintic treatment in porcine neurocysticercosis. |
CTLA, DEX, EB, ETN, IFN, IL, MMP, NCC, PECAM, PZQ, TGF, TIMP, TNF, VEGF |
| 78 |
2017 |
Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy. |
Ang2-BD, RTK, YSD |
| 79 |
2017 |
Vascular and cellular changes accompany altered expression of angiopoietins in placenta of non-complicated ART pregnancies. |
--- |
| 80 |
2016 |
Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli. |
EHEC, HUS |
| 81 |
2016 |
Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C. |
AUC-ROC, CHC, ELISA |
| 82 |
2016 |
Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems. |
VE-PTP, VEGF |
| 83 |
2016 |
Angiopoietins in Human Breast Milk. |
--- |
| 84 |
2016 |
Association of markers of endothelial dysregulation Ang1 and Ang2 with acute kidney injury in critically ill patients. |
AKI, CI, ICU, IL, RR |
| 85 |
2016 |
Calpeptin Prevents Malignant Pleural Mesothelioma Cell Proliferation via the Angiopoietin1/Tie2 System. |
MPM |
| 86 |
2016 |
Circulating angiopoietin-1 and -2 in patients with stable and exacerbated asthma. |
FEV1, FVC |
| 87 |
2016 |
Comparison between Variable and Conventional Volume-Controlled Ventilation on Cardiorespiratory Parameters in Experimental Emphysema. |
CINC, ELA, IL, NV, PEEP, SAL, VCV, VEGF, VILI, VT |
| 88 |
2016 |
Dexamethasone reverses the effects of high glucose on human retinal endothelial cell permeability and proliferation invitro. |
DMO, REC |
| 89 |
2016 |
Disruption of vascular endothelial homeostasis in systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The dynamic roles of angiopoietin-1 and -2. |
HC, KD, MAS, polyJIA, sJIA, VAHS |
| 90 |
2016 |
Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria. |
--- |
| 91 |
2016 |
Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion. |
ICAM, IL, MCP, ME, RVO, VEGF |
| 92 |
2016 |
Effects of total saponins from Rhizoma Dioscoreae Nipponicae on expression of vascular endothelial growth factor and angiopoietin-2 and Tie-2 receptors in the synovium of rats with rheumatoid arthritis. |
RA, TS-RDN, VEGF |
| 93 |
2016 |
Fast Versus Slow Recruitment Maneuver at Different Degrees of Acute Lung Inflammation Induced by Experimental Sepsis. |
PEEP, RMs, VT |
| 94 |
2016 |
Glutamine Administration Modulates Endothelial Progenitor Cell and Lung Injury in Septic Mice. |
CLP, EPCs, Gln, NC, SG, SS |
| 95 |
2016 |
IL-33-Dependent Endothelial Activation Contributes to Apoptosis and Renal Injury in Orientia tsutsugamushi-Infected Mice. |
EC, eNOS, ET-1, HUVEC, rIL-33, sST2, WT |
| 96 |
2016 |
Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis. |
AE-IPF, FVC, IPF |
| 97 |
2016 |
Increased angiogenic factors in exhaled breath condensate of children with severe asthma - New markers of disease progression? |
DPP, EBC, MMP, TSP, VEGF |
| 98 |
2016 |
Pulmonary vascular inflammation: effect of TLR signalling on angiopoietin/TIE regulation. |
SMC, TLR |
| 99 |
2016 |
Sustained Elevation of Vascular Endothelial Growth Factor and Angiopoietin-2 Levels After Transcatheter Aortic Valve Replacement. |
TAVR, VEGF |
| 100 |
2015 |
Angiopoietin and vascular endothelial growth factor expression in colorectal disease models. |
CRC, DMH, DSS, Tie, UC, VEGF |
|
A Search Service for Abbreviation / Long Form
